Related references
Note: Only part of the references are listed.Does the method of botulinum neurotoxin injection for limb spasticity affect outcomes? A systematic review
Aaron K. Chan et al.
CLINICAL REHABILITATION (2017)
Botulinum toxin for the treatment of depression
Katlein Franca et al.
DERMATOLOGIC THERAPY (2017)
Immunological aspects of botulinum toxin therapy
Dirk Dressler et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Bruxism in Movement Disorders: A Comprehensive Review
Bruno Ella et al.
JOURNAL OF PROSTHODONTICS-IMPLANT ESTHETIC AND RECONSTRUCTIVE DENTISTRY (2017)
Immunological aspects of botulinum toxin therapy
Dirk Dressler et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry
Richard M. Trosch et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity The TOWER study
Joerg Wissel et al.
NEUROLOGY (2017)
Dystonia treatment Patterns of medication use in an international cohort
Sarah Pirio Richardson et al.
NEUROLOGY (2017)
BOTULINUM NEUROTOXIN TYPE A-CLEAVED SNAP25 IS CONFINED TO PRIMARY MOTOR NEURONS AND LOCALIZED ON THE PLASMA MEMBRANE FOLLOWING INTRAMUSCULAR TOXIN INJECTION
Brian B. Cai et al.
NEUROSCIENCE (2017)
Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology
Marco Pirazzini et al.
PHARMACOLOGICAL REVIEWS (2017)
Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H
Guorui Yao et al.
TOXINS (2017)
Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature
Michael W. Peck et al.
TOXINS (2017)
Research Priorities in Limb and Task-Specific Dystonias
Sarah Pirio Richardson et al.
FRONTIERS IN NEUROLOGY (2017)
Clinical Practice: evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin
Maria Fiorella Contarino et al.
FRONTIERS IN NEUROLOGY (2017)
Safety and efficacy of letibotulinumtoxinA(BOTULAX®) in treatment of post stroke upper limb spasticity: a randomized, double blind, multi-center, phase III clinical trial
Kyung Hee Do et al.
CLINICAL REHABILITATION (2017)
Is there enough evidence to use botulinum toxin injections for bruxism management? A systematic literature review
Giancarlo De la Torre Canales et al.
CLINICAL ORAL INVESTIGATIONS (2017)
Efficacy and Safety of a New Botulinum Toxin Type A Free of Complexing Proteins
Hyun-Mi Oh et al.
TOXINS (2016)
Intrastriatal injection of botulinum neurotoxin-A is not cytotoxic in rat brain - A histological and stereological analysis
Juliane Mehlan et al.
BRAIN RESEARCH (2016)
Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism
Veronica A. Bruno et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2016)
Submolecular recognition regions of the HN domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients
Minako Oshima et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Botulinum toxin treatment failures in cervical dystonia: causes, management, and outcomes
H. A. Jinnah et al.
JOURNAL OF NEUROLOGY (2016)
Botulinum toxin as early intervention for spasticity after stroke or non-progressive brain lesion: A meta-analysis
Raymond L. Rosales et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache Report of the Guideline Development Subcommittee of the American Academy of Neurology
David M. Simpson et al.
NEUROLOGY (2016)
Drooling in Parkinson's disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins
Pushpa Narayanaswami et al.
PARKINSONISM & RELATED DISORDERS (2016)
Botulinum Toxin for the Treatment of Tremor and Tics
Mitesh Lotia et al.
SEMINARS IN NEUROLOGY (2016)
Botulinum Toxin Treatment of Spasticity in Adults and Children
Iman Moeini-Naghani et al.
SEMINARS IN NEUROLOGY (2016)
Preserved micturition after intradetrusor onabotulinumtoxinA injection for treatment of neurogenic bladder dysfunction in Parkinson's disease
Stephanie C. Knuepfer et al.
BMC UROLOGY (2016)
OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial
Victor W. Nitti et al.
JOURNAL OF UROLOGY (2016)
The first non Clostridial botulinum-like toxin cleaves VAMP within the juxtamembrane domain
Irene Zornetta et al.
SCIENTIFIC REPORTS (2016)
Impact of Cervical Dystonia on Work Productivity: An Analysis From a Patient Registry
Eric S. Molho et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2016)
Botulinum toxin for the treatment of bruxism
Neslihan Tinastepe et al.
CRANIO-THE JOURNAL OF CRANIOMANDIBULAR & SLEEP PRACTICE (2015)
An international survey of patients with cervical dystonia
Cynthia Comella et al.
JOURNAL OF NEUROLOGY (2015)
Primary results from the Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE)
Joseph Jankovic et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Hyoid muscle dystonia: A distinct focal dystonia syndrome
E. Norby et al.
PARKINSONISM & RELATED DISORDERS (2015)
Treatment of camptocormia with botulinum toxin
Kelly L. Bertram et al.
TOXICON (2015)
Explanation of timing of botulinum neurotoxin effects, onset and duration, and clinical ways of influencing them
Mark Hallett
TOXICON (2015)
Current gaps in basic science knowledge of botulinum neurotoxin biological actions
Ornella Rossetto et al.
TOXICON (2015)
More than at the Neuromuscular Synapse: Actions of Botulinum Neurotoxin A in the Central Nervous System
Riccardo Mazzocchio et al.
NEUROSCIENTIST (2015)
IncobotulinumtoxinA (Xeomin (R)) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated
Virgilio Gerald H. Evidente et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Botulinum neurotoxins: genetic, structural and mechanistic insights
Ornella Rossetto et al.
NATURE REVIEWS MICROBIOLOGY (2014)
All Roads Lead to Neuroscience: The 2013 Nobel Prize in Physiology or Medicine
Nils Brose
NEURON (2014)
Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: A 20-year follow-up
Juan Ramirez-Castaneda et al.
TOXICON (2014)
Diffusion, Spread, and Migration of Botulinum Toxin
Juan Ramirez-Castaneda et al.
MOVEMENT DISORDERS (2013)
Flu-like Symptoms and Associated Immunological Response Following Therapy with Botulinum Toxins
Jose Fidel Baizabal-Carvallo et al.
NEUROTOXICITY RESEARCH (2013)
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders
Mark Hallett et al.
TOXICON (2013)
Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule
M. Zouhair Atassi et al.
IMMUNOBIOLOGY (2012)
ELIMINATION OF DYSPHAGIA USING ULTRASOUND GUIDANCE FOR BOTULINUM TOXIN INJECTIONS IN CERVICAL DYSTONIA
Justin S. Hong et al.
MUSCLE & NERVE (2012)
Evidence for Anterograde Transport and Transcytosis of Botulinum Neurotoxin A (BoNT/A)
Laura Restani et al.
JOURNAL OF NEUROSCIENCE (2011)
Characterization of diffusion and duration of action of a new botulinum toxin type A formulation
Hongran F. Stone et al.
TOXICON (2011)
Flu-like symptoms following botulinum toxin therapy
Jose F. Baizabal-Carvallo et al.
TOXICON (2011)
Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia
Kapil D. Sethi et al.
JOURNAL OF MEDICAL ECONOMICS (2011)
Botulinum toxin type B vs. type A in toxin-naive patients with cervical dystonia: Randomized, double-blind, noninferiority trial
Eric J. Pappert et al.
MOVEMENT DISORDERS (2008)
Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay
Mitchell F. Brin et al.
MOVEMENT DISORDERS (2008)
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) - Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
D. M. Simpson et al.
NEUROLOGY (2008)
Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) - Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
M. Naumann et al.
NEUROLOGY (2008)
Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review) - Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
D. M. Simpson et al.
NEUROLOGY (2008)
Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia
CL Comella et al.
NEUROLOGY (2005)
Historical notes on botulism, Clostridium batulinum, botulinum toxin, and the idea of the therapeutic use of the toxin
FJ Erbguth
MOVEMENT DISORDERS (2004)
Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia
J Jankovic et al.
NEUROLOGY (2003)
Botulinum toxin as a biological weapon - Medical and public health management
SS Arnon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Treating severe bruxism with botulinum toxin
EK Tan et al.
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (2000)
Share Paper
